Abstract:The brain microenvironment is tightly regulated, and the blood-brain barrier (BBB) plays a pivotal role in maintaining the homeostasis of the central nervous system. It effectively safeguards brain tissue from harmful substances in peripheral blood. However, both acute pathological factors and age-related biodegradation have the potential to compromise the integrity of the BBB and are associated with chronic neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), as well as Epilepsy (EP). This association arises due to infiltration of peripheral foreign bodies including microorganisms, immune-inflammatory mediators, and plasma proteins into the central nervous system when the BBB is compromised. Nevertheless, these partial and generalized understandings do not prompt a shift from passive to active treatment approaches. Therefore, it is imperative to acquire a comprehensive and in-depth understanding of the intricate molecular mechanisms underlying vascular disease alterations associated with the onset and progression of chronic neurodegenerative disorders, as well as the subsequent homeostatic changes triggered by BBB impairment. The present article aims to systematically summarize and review recent scientific work with a specific focus on elucidating the fundamental mechanisms underlying BBB damage in AD, PD, and EP as well as their consequential impact on disease progression. These findings not only offer guidance for optimizing the physiological function of the BBB, but also provide valuable insights for developing intervention strategies aimed at early restoration of BBB structural integrity, thereby laying a solid foundation for designing drug delivery strategies centered around the BBB.

Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

Revealing the mechanisms of blood-brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention

Establishment and Dysfunction of the Blood-Brain Barrier

The blood-brain barrier in health and chronic neurodegenerative disorders

Blood-brain barrier-morphology, modulation and clinical implications

Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease

Research progress in cellular and molecular mechanisms related to permeability alteration of blood-brain barrier

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics

The Blood-Brain Barrier, a Key Bridge to Treat Neurodegenerative Diseases.

New insight into neurological degeneration: Inflammatory cytokines and blood–brain barrier

The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders

Blood-brain barrier endothelial cells in neurodegenerative diseases: Signals from the "barrier"

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Blood-derived factors to brain communication in brain diseases

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential

Blood-brain barrier disruption following brain injury: Implications for clinical practice

The Progress in Molecular Transport and Therapeutic Development in Human Blood–Brain Barrier Models in Neurological Disorders

Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease

The Role of VE-cadherin in Blood-brain Barrier Integrity under Central Nervous System Pathological Conditions

Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases